Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral vs Subcutaneous Methotrexate in Early Rheumatoid Arthritis
NCT05353829Phase 4Active, not recruiting
- Sponsor
- Region Västerbotten
- Start
- Apr 2022
- Primary completion
- Dec 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of methotrexate in rheumatoid arthritis (RA), sponsored by Region Västerbotten. Started Apr 2022; status: active, not recruiting.
02
Drugs
methotrexate
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT05353829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05353829.